EPGNF
Price:
$1.12
Market Cap:
$612.61K
Epigenomics AG is a molecular diagnostics company, which engages in the development and commercializing of proprietary products for the screening and diagnosis of cancer. It offers Epi proColon, a blood-based test for the early detection of colorectal cancer; Epi proLung, a confirmatory test that aids in the diagnosis of lung cancer, Epi BiSKit, a kit for the preparation of purified, bisulfite-converted DNA and, HCCBloodTest, a blood test for cirrhotic patients at high-risk for the development of hepatocellular carcinoma. The company was founded by Oliver Schacht, Christian Piepenbrock, Kurt Berlin, Jörn Walter, and Ivo G. Gut in 1998 and is headquartered in Berlin, Germany.
Industry
Medical - Specialties
IPO Date
2010-12-31
Stock Exchange
OTC
Ticker
EPGNF
According to Epigenomics AG’s latest financial reports and current stock price. The company's current PE Ratio is -0.30. This represents a change of -55.53% compared to the average of -0.67 of the last 4 quarters.
The mean historical PE Ratio of Epigenomics AG over the last ten years is -127.93. The current -0.30 PE Ratio has changed -76.55% with respect to the historical average. Over the past ten years (40 quarters), EPGNF's PE Ratio was at its highest in in the September 2021 quarter at 1.29. The PE Ratio was at its lowest in in the December 2016 quarter at -1654.55.
Average
-127.93
Median
-7.02
Minimum
-709.43
Maximum
-0.57
Discovering the peaks and valleys of Epigenomics AG PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 788.67%
Maximum Annual PE Ratio = -0.57
Minimum Annual Increase = -99.33%
Minimum Annual PE Ratio = -709.43
| Year | PE Ratio | Change |
|---|---|---|
| 2022 | -0.57 | -96.10% |
| 2021 | -14.74 | 788.67% |
| 2020 | -1.66 | -45.40% |
| 2019 | -3.04 | -23.74% |
| 2018 | -3.98 | -63.13% |
| 2017 | -10.80 | 16.38% |
| 2016 | -9.28 | 95.42% |
| 2015 | -4.75 | -99.33% |
| 2014 | -709.43 | 36.15% |
| 2013 | -521.08 | 102.70% |
The current PE Ratio of Epigenomics AG (EPGNF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-5.66
5-year avg
-4.80
10-year avg
-127.93
Epigenomics AG’s PE Ratio is less than Unity Biotechnology, Inc. (-0.13), less than Telesis Bio, Inc. (-0.00), less than Body and Mind Inc. (-0.11), greater than RushNet, Inc. (-1.00), less than NovelStem International Corp. (0.19), less than PPJ Healthcare Enterprises, Inc. (56.81), greater than Health Logic Interactive Inc. (-3.76), less than China Medicine Corp. (0.18), less than Procyon Corporation (113.04), less than Next Generation Management Corp. (-0.00),
| Company | PE Ratio | Market cap |
|---|---|---|
| -0.13 | $965.60K | |
| -0.00 | $86.23K | |
| -0.11 | $29.54K | |
| -1.00 | $857.64K | |
| 0.19 | $493.32K | |
| 56.81 | $445.24K | |
| -3.76 | $165.84K | |
| 0.18 | $474.24K | |
| 113.04 | $2.11M | |
| -0.00 | $31.16K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Epigenomics AG using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Epigenomics AG or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Epigenomics AG's PE Ratio?
How is the PE Ratio calculated for Epigenomics AG (EPGNF)?
What is the highest PE Ratio for Epigenomics AG (EPGNF)?
What is the 3-year average PE Ratio for Epigenomics AG (EPGNF)?
What is the 5-year average PE Ratio for Epigenomics AG (EPGNF)?
How does the current PE Ratio for Epigenomics AG (EPGNF) compare to its historical average?